Everest Organics Limited (EVERESTO.BO)
INR 257.5
(4.99%)
INR 257.5
(4.99%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 577.88 Million INR | 13.21% |
| 2022 | 510.47 Million INR | 31.63% |
| 2021 | 387.8 Million INR | 69.35% |
| 2020 | 228.98 Million INR | 27.66% |
| 2019 | 179.37 Million INR | -16.26% |
| 2018 | 214.21 Million INR | -2.54% |
| 2017 | 219.79 Million INR | 26.6% |
| 2016 | 173.61 Million INR | -37.25% |
| 2015 | 276.65 Million INR | 16.63% |
| 2014 | 237.21 Million INR | -8.39% |
| 2013 | 258.94 Million INR | 36.97% |
| 2012 | 189.04 Million INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 571.43 Million INR | -1.12% |
| 2023 Q4 | 577.88 Million INR | 2.98% |
| 2023 Q1 | 554.51 Million INR | 8.63% |
| 2023 FY | 577.88 Million INR | 13.21% |
| 2023 Q3 | 561.16 Million INR | 8.59% |
| 2023 Q2 | 516.76 Million INR | -6.81% |
| 2022 Q3 | 379.35 Million INR | -5.93% |
| 2022 FY | 510.47 Million INR | 31.63% |
| 2022 Q2 | 403.25 Million INR | -3.38% |
| 2022 Q1 | 417.35 Million INR | 7.62% |
| 2022 Q4 | 510.47 Million INR | 34.56% |
| 2021 Q2 | 332.35 Million INR | 34.41% |
| 2021 Q1 | 247.26 Million INR | 7.98% |
| 2021 Q3 | 334.77 Million INR | 0.73% |
| 2021 FY | 387.8 Million INR | 69.35% |
| 2021 Q4 | 387.8 Million INR | 15.84% |
| 2020 Q1 | 256.25 Million INR | 16.24% |
| 2020 Q3 | 169.86 Million INR | -28.05% |
| 2020 Q4 | 228.98 Million INR | 34.81% |
| 2020 FY | 228.98 Million INR | 27.66% |
| 2020 Q2 | 236.08 Million INR | -7.87% |
| 2019 FY | 179.37 Million INR | -16.26% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q4 | 220.44 Million INR | 0.0% |
| 2019 Q2 | 222.32 Million INR | -6.63% |
| 2019 Q1 | 238.1 Million INR | -2.48% |
| 2018 Q4 | 244.15 Million INR | 14.42% |
| 2018 FY | 214.21 Million INR | -2.54% |
| 2018 Q3 | 213.38 Million INR | -5.36% |
| 2018 Q2 | 225.47 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q2 | 170.4 Million INR | 0.0% |
| 2017 Q4 | 234.06 Million INR | 0.0% |
| 2017 FY | 219.79 Million INR | 26.6% |
| 2016 Q2 | 169.62 Million INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q4 | 190.7 Million INR | 0.0% |
| 2016 FY | 173.61 Million INR | -37.25% |
| 2015 Q4 | 275.15 Million INR | 0.0% |
| 2015 FY | 276.65 Million INR | 16.63% |
| 2014 FY | 237.21 Million INR | -8.39% |
| 2014 Q4 | 237.21 Million INR | 0.0% |
| 2013 Q2 | 153.75 Million INR | -0.26% |
| 2013 Q4 | 258.94 Million INR | 54.67% |
| 2013 Q1 | 154.15 Million INR | -18.46% |
| 2013 Q3 | 167.41 Million INR | 8.88% |
| 2013 FY | 258.94 Million INR | 36.97% |
| 2012 FY | 189.04 Million INR | 0.0% |
| 2012 Q4 | 189.04 Million INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Chandra Bhagat Pharma Limited | 164.26 Million INR | -251.796% |
| Checkpoint Trends Limited | - INR | -Infinity% |
| GUJARAT INJECT (KERALA) LTD. | - INR | -Infinity% |
| NATURO INDIABULL LIMITED | 121.49 Million INR | -375.632% |
| NEXUS SURGICAL AND MEDICARE LI | - INR | -Infinity% |
| Rajnish Wellness Limited | 49.24 Million INR | -1073.567% |
| Rama Vision Limited | 187.6 Million INR | -208.039% |
| Vivo Bio Tech Limited | 730.63 Million INR | 20.906% |